ClinicalTrials.gg
CompletedNCT07419763Updated Feb 19, 2026

Intra Oral Appliance (IOA) Model Evaluating the Efficacy of Sensitive Toothpaste

An interventional study of Negative Control Toothpaste and Active Comparator in Dental Caries, sponsored by Church & Dwight Company, Inc.. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-19.

Sponsored by Church & Dwight Company, Inc. · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Apr 2025, registered Feb 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 194 studies in Dental Caries with a site in United States — 17 open to participants now, 20 under way, 3 of them phase 3. Dental Caries · United States.

Enrollment
128th of 169
30 · median 60
Started
2025
with 7 others
No phase
111 of 194
14 open now
Registered
188th of 194
by date

Among the 194 studies in Dental Caries with a site in United States, this one is the 128th largest by enrollment of the 169 interventional ones that give a count, is one of 8 that started in 2025, is one of 111 with no phase, and was the 188th registered.

Dental Caries

1,176 studies on the registry are indexed under Dental Caries; 209 are open to participants now.

Browse Dental Caries studies →

Open to participants now

17 of the 194 studies in Dental Caries with a site in United States are open now. Recruiting first, the newest first:

12 more — sign in →

All 17 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 86 Dental Caries studies recruiting now, 18 (21%) set no upper age limit and 66 (77%) stop at 75 or younger; 60 take children under 18; 53 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 194 studies in Dental Caries with a site in United States, or all of them as a file.
02

Study summary

This single-center, randomized, double-blind, three-period crossover in situ study evaluated the enamel remineralization potential and fluoride bioavailability of three dentifrices: a fluoride-free negative control, a positive control with 0.243% sodium fluoride, and an investigational dentifrice containing 0.243% sodium fluoride, 5.0% potassium nitrate (KNO₃), and 20% sodium bicarbonate. Adult subjects wore acrylic palatal appliances containing demineralized enamel specimens for three 7-day treatment periods, each preceded by a 5-day fluoride-free washout. Primary outcomes were percent surface microhardness recovery (%SMHR) and enamel fluoride concentration.

Read the detailed description

This in situ intraoral appliance (IOA) model evaluates anticaries potential by exposing demineralized enamel specimens to oral conditions while allowing for ex vivo treatment assessments. Subjects wore acrylic palatal appliances containing four enamel specimens covered with steel gauze to promote plaque formation. Each of the three treatment periods lasted seven days and included twice-daily toothbrushing and dentifrice slurry swishing, plus three daily sucrose challenges. A minimum 5-day fluoride-free washout preceded each period. Post-treatment specimens were analyzed for %SMHR and enamel fluoride concentration.

03

Conditions studied

  • Dental Caries

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults ≥18 years
  • Good general and oral health
  • Normal unstimulated saliva flow (≥1.5 mL unstimulated saliva in 5 minutes)
  • ≥16 teeth and functional maxillary dentition to support palatal appliance
  • Agree to abstain from other oral care products and preventive dental procedures during study
  • No advanced periodontal disease, no visible untreated caries
  • If female, not pregnant or breastfeeding (self-reported)
  • No significant oral soft tissue pathology; no peri/oral piercings; no removable partial dentures
  • No antibiotics or immunosuppressives within 30 days of screening
  • No palatal torus; no medical condition that would interfere with safety
  • No allergy or significant adverse events to impression materials, acrylics, or common oral product

Exclusion criteria

Exclusion Criteria:

  • Unable to tolerate appliance or comply with procedures
  • Oral pathology that interferes with participation
  • Use of fluoride toothpaste during
  • Participation in another appliance study within the last 4 week
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Washout period

A planned gap after a treatment, so that its effects can lessen before the study treatment or a study assessment. Ask the study team and the doctor who prescribed it before changing any medicine.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Placebo comparator
    Negative Control Toothpaste

    Fluoride-free dentifrice (0 ppm fluoride). Used for twice-daily brushing and slurry swishing per protocol during each 7-day test period.

    Drug: Negative Control Toothpaste

  • Active comparator
    Comparator

    Sodium fluoride dentifrice (0.243% sodium fluoride). Used for twice-daily brushing and slurry swishing per protocol during each 7-day test period.

    Drug: Active Comparator

  • Experimental
    Test Toothpaste

    Test dentifrice containing 0.243% sodium fluoride, 5.0% potassium nitrate, and 20% sodium bicarbonate. Used for twice-daily brushing and slurry swishing per protocol during each 7-day test period.

    Drug: Test toothpaste

Interventions

  • DrugNegative Control Toothpaste

    Fluoride-free toothpaste

  • DrugActive Comparator

    Commercially available fluoride toothpaste

  • DrugTest toothpaste

    Investigational fluoride toothpaste

06

What researchers measure

Primary outcomes

  1. Percent Surface Microhardness Recovery (%SMHR)

    Time frame: End of each 7-day test period (three periods total)

  2. Enamel Fluoride Concentration (EFU)

    Post-treatment enamel fluoride concentration (µg F/cm³)

    Time frame: End of each 7-day test period (three periods total)

07

Study locations

1 site
  • Therametric Technologies, Inc.
    Noblesville, Indiana 46060, United States
08

References and documents

Individual participant data

Plan to share: No — The sponsor does not plan to share individual participant data (IPD) from this study. Summary results will be provided as required; de-identified datasets or additional supporting documents will not be made available.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2025 to primary completion in Jun 2025, 1 month.

Of 33 industry-sponsored interventional studies with no phase under Dental Caries, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 24. This study's 1 month is below that.

Counting every sponsor, half of 502 studies reached it within 15 months; a quarter within 7 and three quarters within 29.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 12, 2026
First posted
Feb 19, 2026
StartActual
Apr 15, 2025
Primary completionActual
Jun 10, 2025
CompletionActual
Jun 10, 2025
Last update
Feb 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07419763
Responsible party
Sponsor
First posted
Feb 19, 2026
Start date
Apr 15, 2025
Primary completion
Jun 10, 2025
Completion
Jun 10, 2025
Last update
Feb 19, 2026

Study contacts

Annahita Ghassemi, PhD
study director · Church & Dwight, Inc.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion